Adicet Bio Stock (NASDAQ: ACET) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 10.00 / 897.38K |
Day Range | - - - |
52 Wk Range | 1.05 - 3.77 |
Market Cap | $126.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 5.88% |
Days to Cover | 10.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adicet Bio (NASDAQ:ACET) through any online brokerage.
Other companies in Adicet Bio’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Citius Oncology (NASDAQ:CTOR), Agenus (NASDAQ:AGEN), aTyr Pharma (NASDAQ:ATYR) and Century Therapeutics (NASDAQ:IPSC).
Adicet Bio has a consensus price target of $15.00.
The stock price for Adicet Bio (NASDAQ: ACET) is $1.54 last updated September 19, 2024 at 5:39 PM EDT.
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on October 9, 2018 to stockholders of record on September 21, 2018.
Adicet Bio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Adicet Bio.
Adicet Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.